WO2005113812A8 - Collections of matched biological reagents and methods for identifying matched reagents - Google Patents

Collections of matched biological reagents and methods for identifying matched reagents

Info

Publication number
WO2005113812A8
WO2005113812A8 PCT/US2005/013914 US2005013914W WO2005113812A8 WO 2005113812 A8 WO2005113812 A8 WO 2005113812A8 US 2005013914 W US2005013914 W US 2005013914W WO 2005113812 A8 WO2005113812 A8 WO 2005113812A8
Authority
WO
WIPO (PCT)
Prior art keywords
reagents
matched
biological
methods
collections
Prior art date
Application number
PCT/US2005/013914
Other languages
French (fr)
Other versions
WO2005113812A2 (en
Inventor
John Carrino
Feng Liang
Siamek Baharloo
Barry I Schweitzer
Original Assignee
Invitrogen Corp
John Carrino
Feng Liang
Siamek Baharloo
Barry I Schweitzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/830,074 external-priority patent/US20050240352A1/en
Application filed by Invitrogen Corp, John Carrino, Feng Liang, Siamek Baharloo, Barry I Schweitzer filed Critical Invitrogen Corp
Priority to JP2007509690A priority Critical patent/JP2007535040A/en
Priority to EP05779954A priority patent/EP1743039A2/en
Publication of WO2005113812A2 publication Critical patent/WO2005113812A2/en
Publication of WO2005113812A8 publication Critical patent/WO2005113812A8/en
Priority to US11/371,354 priority patent/US20060275794A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/10—Ontologies; Annotations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

Provided herein are collections of matched biological reagents selected from a larger collection of biological reagents, wherein the collection of matched biological reagents relate to a biological element. Also provided are methods for selling an isolated biomolecule or biological research reagent in a collection of matched biological reagents, and methods for selecting an isolated biomolecule or biological research reagent from a collection of biological reagents.
PCT/US2005/013914 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents WO2005113812A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2007509690A JP2007535040A (en) 2004-04-23 2005-04-22 Collection of compatible biological reagents and methods for identifying compatible reagents
EP05779954A EP1743039A2 (en) 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents
US11/371,354 US20060275794A1 (en) 2005-03-07 2006-03-07 Collections of matched biological reagents and methods for identifying matched reagents

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US10/830,074 US20050240352A1 (en) 2004-04-23 2004-04-23 Online procurement of biologically related products/services using interactive context searching of biological information
US10/830,074 2004-04-23
US58794104P 2004-07-14 2004-07-14
US58815804P 2004-07-14 2004-07-14
US60/587,941 2004-07-14
US60/588,158 2004-07-14
US59154104P 2004-07-26 2004-07-26
US60/591,541 2004-07-26
US59223904P 2004-07-28 2004-07-28
US60/592,239 2004-07-28
US60829304P 2004-09-08 2004-09-08
US60/608,293 2004-09-08
US65139005P 2005-02-08 2005-02-08
US60/651,390 2005-02-08
US95358605P 2005-02-15 2005-02-15
US60/953,586 2005-02-15
US65949205P 2005-03-07 2005-03-07
US60/659,492 2005-03-07
US66520005P 2005-03-25 2005-03-25
US60/665,200 2005-03-25
US67304505P 2005-04-19 2005-04-19
US1005705A 2005-04-19 2005-04-19
US60/673,045 2005-04-19

Publications (2)

Publication Number Publication Date
WO2005113812A2 WO2005113812A2 (en) 2005-12-01
WO2005113812A8 true WO2005113812A8 (en) 2006-02-02

Family

ID=35428938

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/013914 WO2005113812A2 (en) 2004-04-23 2005-04-22 Collections of matched biological reagents and methods for identifying matched reagents

Country Status (1)

Country Link
WO (1) WO2005113812A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9422539B2 (en) 2010-07-12 2016-08-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8163482B2 (en) 2006-02-23 2012-04-24 Nicholas Katsanis BBS10 related diagnostic methods for Bardet-Biedl syndrome
KR100954322B1 (en) * 2006-06-14 2010-04-21 주식회사 엘지생명과학 Gene familyLBFL313 associated with pancreatic cancer
JP5354634B2 (en) * 2007-01-25 2013-11-27 国立大学法人大阪大学 Human ABH8 protein, gene encoding it, and therapeutic or diagnostic uses thereof
JP5611814B2 (en) 2007-03-27 2014-10-22 イントレキソン コーポレーション MEK ligand and polynucleotide encoding MEK ligand
US8580502B2 (en) * 2007-06-04 2013-11-12 Centre For Addiction And Mental Health Methods of screening a subject for FHL1 mutations associated with novel X-linked muscular myopathies
WO2008151428A1 (en) * 2007-06-11 2008-12-18 University Of Western Ontario Novel compositions for modulating mrna translation
EP2420509B1 (en) * 2007-10-02 2018-01-24 Universität zu Köln Novel marker genes for regulatory t cells from human blood
WO2010092974A1 (en) * 2009-02-11 2010-08-19 国立大学法人東京大学 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor
DK3255146T3 (en) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities
WO2011062962A2 (en) * 2009-11-17 2011-05-26 The Trustees Of The University Of Pennsylvania Smndelta7 degron: novel compositions and methods of use
JP6294074B2 (en) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of isoleucyl-tRNA synthetase
JP5843170B2 (en) 2010-09-30 2016-01-13 国立研究開発法人理化学研究所 Method for treating glioma, method for examining glioma, method for delivering desired substance to glioma, and drug used in these methods
CN104870634A (en) * 2012-07-19 2015-08-26 宾夕法尼亚州研究基金会 Regenerating functional neurons for treatment of disease and injury in the nervous system
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
EP3016973A1 (en) * 2013-07-05 2016-05-11 INSERM - Institut National de la Santé et de la Recherche Médicale Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof
GB201415273D0 (en) * 2014-08-28 2014-10-15 Thermo Fisher Scient Bremen Data processing device and method for the evaluation of mass spectrometry data
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
WO2016100049A1 (en) 2014-12-18 2016-06-23 Edico Genome Corporation Chemically-sensitive field effect transistor
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
EP3459115A4 (en) 2016-05-16 2020-04-08 Agilome, Inc. Graphene fet devices, systems, and methods of using the same for sequencing nucleic acids
US11315661B2 (en) * 2017-02-16 2022-04-26 Becton, Dickinson And Company Methods and systems for providing epitope tagged biomolecules
WO2018195338A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
WO2020165775A1 (en) * 2019-02-11 2020-08-20 Qualus Research Spa Production and uses of artificial histone h1 for analyzing, diagnosing, treating, and/or preventing senescence
WO2023081455A2 (en) * 2021-11-08 2023-05-11 Memorial Sloan-Kettering Cancer Center Immune cells expressing glucose transporter 5 (gluts) and compositions and methods including the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9127268B2 (en) 2009-12-11 2015-09-08 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9328340B2 (en) 2009-12-11 2016-05-03 Atyr Pharma, Inc. Amino acyl tRNA synthetases for modulating inflammation
US9540628B2 (en) 2009-12-11 2017-01-10 Atyr Pharma, Inc. Aminoacyl tRNA synthetases for modulating inflammation
US9422539B2 (en) 2010-07-12 2016-08-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9273302B2 (en) 2012-02-16 2016-03-01 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9587235B2 (en) 2013-03-15 2017-03-07 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates

Also Published As

Publication number Publication date
WO2005113812A2 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2005113812A8 (en) Collections of matched biological reagents and methods for identifying matched reagents
SG131130A1 (en) Biochip for sorting and lysing biological samples
WO2007065025A3 (en) Method of dna analysis using micro/nanochannel
WO2006121997A3 (en) Self-contained biological analysis
WO2004051218A3 (en) Multiplex amplification of polynucleotides
HK1095381A1 (en) Sample collection cup with integrated sample analysis system
WO2006124641A3 (en) Anti-mesothelin antibodies useful for immunological assays
IL175629A0 (en) Sample collection cup with integrated activatable sample analysis system
AU2002311773A1 (en) Labeled cells for use as an internal functional control in rare cell detection assays
WO2004070020A3 (en) Glyphosate tolerant alfalfa events and methods for detection thereof
MX2007012486A (en) Stilbazium research assays.
WO2007039290A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders
EP1778470A4 (en) Biological specimen collection, transportation, and dispensing system
WO2011046614A3 (en) Methods and systems for phylogenetic analysis
EP1668338A4 (en) Automated cytological sample classification
WO2007085827A3 (en) Epigenetic analyses
WO2006036735A3 (en) Method for detecting and quantitating multiple subcellular components
EP1627038A4 (en) Microparticle based biochip systems and uses thereof
WO2004024957A3 (en) Method for detection of micro-metastasis
WO2007037910A3 (en) Specific removal of activated immune cells
WO2005090596A3 (en) Assay for detecting and identifying micro-organisms
WO2007094752A3 (en) Biobriefcase
WO2007033367A3 (en) Salivary protein and rna for breast cancer detection
WO2008013975A3 (en) Methods and kits for measurement of lymphocyte function
WO2001069247A3 (en) Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 48/2005 UNDER (30) REPLACE "INV-1005-PV7" BY "60/673,045"

D17 Declaration under article 17(2)a
WWE Wipo information: entry into national phase

Ref document number: 2007509690

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005779954

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005779954

Country of ref document: EP